Logo image of BTSGU

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) Stock Fundamental Analysis

NASDAQ:BTSGU - Nasdaq - US10950A2050 - Currency: USD

70.6  +1.77 (+2.57%)

After market: 70.1833 -0.42 (-0.59%)

Fundamental Rating

4

Taking everything into account, BTSGU scores 4 out of 10 in our fundamental rating. BTSGU was compared to 103 industry peers in the Health Care Providers & Services industry. BTSGU has an average financial health and profitability rating. BTSGU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BTSGU was profitable.
BTSGU had a positive operating cash flow in the past year.
In multiple years BTSGU reported negative net income over the last 5 years.
Of the past 5 years BTSGU 4 years had a positive operating cash flow.
BTSGU Yearly Net Income VS EBIT VS OCF VS FCFBTSGU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.98%, BTSGU is in line with its industry, outperforming 50.49% of the companies in the same industry.
BTSGU has a Return On Equity of 3.39%. This is comparable to the rest of the industry: BTSGU outperforms 56.31% of its industry peers.
With a Return On Invested Capital value of 4.48%, BTSGU perfoms like the industry average, outperforming 53.40% of the companies in the same industry.
BTSGU had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.55%.
The 3 year average ROIC (3.45%) for BTSGU is below the current ROIC(4.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROIC 4.48%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSGU Yearly ROA, ROE, ROICBTSGU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

BTSGU's Profit Margin of 0.49% is in line compared to the rest of the industry. BTSGU outperforms 50.49% of its industry peers.
BTSGU has a Operating Margin of 2.15%. This is comparable to the rest of the industry: BTSGU outperforms 48.54% of its industry peers.
In the last couple of years the Operating Margin of BTSGU has grown nicely.
BTSGU has a worse Gross Margin (13.46%) than 69.90% of its industry peers.
BTSGU's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSGU Yearly Profit, Operating, Gross MarginsBTSGU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BTSGU is destroying value.
BTSGU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BTSGU has more shares outstanding
BTSGU has a better debt/assets ratio than last year.
BTSGU Yearly Shares OutstandingBTSGU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSGU Yearly Total Debt VS Total AssetsBTSGU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BTSGU has an Altman-Z score of 4.04. This indicates that BTSGU is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.04, BTSGU is in the better half of the industry, outperforming 73.79% of the companies in the same industry.
The Debt to FCF ratio of BTSGU is 19.98, which is on the high side as it means it would take BTSGU, 19.98 years of fcf income to pay off all of its debts.
BTSGU's Debt to FCF ratio of 19.98 is in line compared to the rest of the industry. BTSGU outperforms 40.78% of its industry peers.
A Debt/Equity ratio of 1.48 is on the high side and indicates that BTSGU has dependencies on debt financing.
BTSGU's Debt to Equity ratio of 1.48 is on the low side compared to the rest of the industry. BTSGU is outperformed by 71.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Altman-Z 4.04
ROIC/WACC0.51
WACC8.76%
BTSGU Yearly LT Debt VS Equity VS FCFBTSGU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.73 indicates that BTSGU should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.73, BTSGU is in the better half of the industry, outperforming 63.11% of the companies in the same industry.
BTSGU has a Quick Ratio of 1.37. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BTSGU (1.37) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.37
BTSGU Yearly Current Assets VS Current LiabilitesBTSGU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

BTSGU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.85%, which is quite impressive.
The Revenue has grown by 27.65% in the past year. This is a very strong growth!
BTSGU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.01% yearly.
EPS 1Y (TTM)92.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
Revenue 1Y (TTM)27.65%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%

3.2 Future

The Earnings Per Share is expected to grow by 29.97% on average over the next years. This is a very strong growth
BTSGU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.63% yearly.
EPS Next Y56.48%
EPS Next 2Y39.35%
EPS Next 3Y31.48%
EPS Next 5Y29.97%
Revenue Next Year9.89%
Revenue Next 2Y11.06%
Revenue Next 3Y11.46%
Revenue Next 5Y7.63%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BTSGU Yearly Revenue VS EstimatesBTSGU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
BTSGU Yearly EPS VS EstimatesBTSGU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

BTSGU is valuated quite expensively with a Price/Earnings ratio of 95.41.
Compared to the rest of the industry, the Price/Earnings ratio of BTSGU is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.03. BTSGU is valued rather expensively when compared to this.
BTSGU is valuated quite expensively with a Price/Forward Earnings ratio of 66.10.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BTSGU is on the same level as its industry peers.
BTSGU's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.28.
Industry RankSector Rank
PE 95.41
Fwd PE 66.1
BTSGU Price Earnings VS Forward Price EarningsBTSGU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BTSGU is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as BTSGU.
Industry RankSector Rank
P/FCF 97.67
EV/EBITDA 32.76
BTSGU Per share dataBTSGU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

BTSGU's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BTSGU's earnings are expected to grow with 31.48% in the coming years.
PEG (NY)1.69
PEG (5Y)N/A
EPS Next 2Y39.35%
EPS Next 3Y31.48%

4

5. Dividend

5.1 Amount

BTSGU has a Yearly Dividend Yield of 4.90%, which is a nice return.
Compared to an average industry Dividend Yield of 2.98, BTSGU pays a better dividend. On top of this BTSGU pays more dividend than 98.06% of the companies listed in the same industry.
BTSGU's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 4.9%

5.2 History

BTSGU is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BTSGU Yearly Dividends per shareBTSGU Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DPN/A
EPS Next 2Y39.35%
EPS Next 3Y31.48%
BTSGU Yearly Income VS Free CF VS DividendBTSGU Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27

NASDAQ:BTSGU (8/5/2025, 4:17:21 PM)

After market: 70.1833 -0.42 (-0.59%)

70.6

+1.77 (+2.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners53.2%
Inst Owner ChangeN/A
Ins Owners2.93%
Ins Owner ChangeN/A
Market Cap12.45B
Analysts84.21
Price Target101.79 (44.18%)
Short Float %0.02%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield 4.9%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date07-15 2025-07-15 (0.8437)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.16%
Min EPS beat(2)-2.7%
Max EPS beat(2)97.01%
EPS beat(4)1
Avg EPS beat(4)3.84%
Min EPS beat(4)-40.94%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.12%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.86%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.89%
PT rev (3m)12.53%
EPS NQ rev (1m)-3.63%
EPS NQ rev (3m)34.23%
EPS NY rev (1m)1.38%
EPS NY rev (3m)47.27%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)2.97%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)3.21%
Valuation
Industry RankSector Rank
PE 95.41
Fwd PE 66.1
P/S 1.08
P/FCF 97.67
P/OCF 60.98
P/B 7.38
P/tB N/A
EV/EBITDA 32.76
EPS(TTM)0.74
EY1.05%
EPS(NY)1.07
Fwd EY1.51%
FCF(TTM)0.72
FCFY1.02%
OCF(TTM)1.16
OCFY1.64%
SpS65.58
BVpS9.57
TBVpS-7.09
PEG (NY)1.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROCE 5.67%
ROIC 4.48%
ROICexc 4.54%
ROICexgc 14.07%
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
FCFM 1.1%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Debt/EBITDA 5.59
Cap/Depr 38.81%
Cap/Sales 0.66%
Interest Coverage 1.22
Cash Conversion 45.71%
Profit Quality 222.79%
Current Ratio 1.73
Quick Ratio 1.37
Altman-Z 4.04
F-Score6
WACC8.76%
ROIC/WACC0.51
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
EPS Next Y56.48%
EPS Next 2Y39.35%
EPS Next 3Y31.48%
EPS Next 5Y29.97%
Revenue 1Y (TTM)27.65%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%
Revenue Next Year9.89%
Revenue Next 2Y11.06%
Revenue Next 3Y11.46%
Revenue Next 5Y7.63%
EBIT growth 1Y60.42%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year54.27%
EBIT Next 3Y23.8%
EBIT Next 5YN/A
FCF growth 1Y-141.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.72%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%